The first influenza vaccine was developed in 1938 by American scientists Thomas Francis Jr. and Jonas Salk, who isolated the virus and created an inactivated vaccine. Mass production began during World War II to protect troops.
These initial vaccines used killed viruses grown in chicken embryos. The process required growing the virus, inactivating it with chemicals, then purifying it. This method remains the foundation of most flu vaccines today.
| Year | Development | Significance |
|---|---|---|
| 1938 | First influenza virus isolation | Enabled vaccine development |
| 1945 | Large-scale production begins | Protected WWII military personnel |
| 1960s | Egg-based production standardized | Established current manufacturing process |
Influenza viruses mutate rapidly, creating new strains each year. The 1947 discovery of antigenic drift explained why previous immunity didn't always protect against new flu seasons. This led to annual reformulation of vaccines to match circulating strains.
Many assume flu shots were available immediately after the 1918 pandemic, but vaccine development took decades longer. The first successful vaccine appeared in 1938, nearly 20 years after the pandemic.
Another misconception is that early vaccines were unsafe. While side effects like soreness occurred, serious reactions were rare. Modern vaccines maintain this safety profile while improving effectiveness.
I remember seeing archival footage of 1940s vaccination campaigns in schools and workplaces. These early programs demonstrated the public health benefits of widespread immunization, a practice still used today.
From the original inactivated vaccines to today's recombinant and cell-based options, influenza vaccination has improved. The CDC recommends annual flu shots for everyone over six months old, with effectiveness varying yearly.
Some people wonder do flu shots make you feel bad due to side effects. While minor reactions can occur, they're typically less severe than actual flu symptoms.
According to the WHO, global vaccine production capacity now exceeds 1.5 billion doses annually. This notable progress from the 1938 breakthrough demonstrates how far influenza prevention has come.